Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
PASG
PASG
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PASG News
Top Analysts Recommend 3 Biotech Stocks to Purchase Now, 11/12/2025
Nov 12 2025
TipRanks
PASSAGE BIO, INC. Reports Reduced Q3 Loss, Surpassing Expectations
Nov 11 2025
NASDAQ.COM
Passage Bio Announces Financial Results for Q3 2025 and Shares Recent Business Updates
Nov 10 2025
Newsfilter
Wall Street Analysts Predict Passage Bio (PASG) Could Soar by 731%: Important Insights Before You Invest
Sep 01 2025
NASDAQ.COM
Guggenheim Maintains Buy on Passage Bio, Lowers Price Target to $10
Aug 14 2025
Benzinga
Upcoming Stock Splits This Week (July 14 to July 18) – Stay Invested
Jul 13 2025
TipRanks
Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights
May 13 2025
Newsfilter
Analysts Offer Insights on Healthcare Companies: Ventyx Biosciences (VTYX), Black Diamond Therapeutics (BDTX) and Passage Bio (PASG)
Mar 07 2025
Business Insider
Chardan Capital Maintains Buy on Passage Bio, Lowers Price Target to $6
Mar 04 2025
Benzinga
Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights
Mar 04 2025
Newsfilter
Passage Bio to Participate in Upcoming Investor Conferences
Feb 26 2025
Newsfilter
Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates
Jan 10 2025
Newsfilter
Wedbush Assumes Passage Bio at Outperform, Announces Price Target of $4
Nov 29 2024
Benzinga
Chardan Capital Maintains Buy on Passage Bio, Maintains $7 Price Target
Nov 14 2024
Benzinga
Passage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
Nov 13 2024
Newsfilter
Passage Bio to Present at Chardan's 8th Annual Genetic Medicines Conference
Sep 23 2024
Newsfilter
Show More News
